Teva Pharmaceutical Industries Ltd. (TEVA) Monday announced a plan to issue $2 million of senior notes through its special purpose finance subsidiaries.
The Israel multinational pharma company said the net proceeds from the offerings, together with cash on hand, will be used to fund purchase of its USD 3.150% Senior Notes due 2026, USD 4.750% Sustainability-Linked Senior Notes due 2027, EUR 3.750% Sustainability-Linked Senior Notes due 2027, USD 7.875% Sustainability-Linked Senior Notes due 2029, EUR 7.375% Sustainability-Linked Senior Notes due 2029 and USD 8.125% Sustainability-Linked Senior Notes due 2031.
Teva Pharmaceutical Finance Netherlands II B.V. intends to offer EUR-denominated Senior Notes and Teva Pharmaceutical Finance Netherlands III B.V. and Teva Pharmaceutical Finance Netherlands IV B.V. intend to offer USD-denominated Senior Notes.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.